Engineered endothelial cells expressing an ETS transcription factor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10961509
APP PUB NO 20180195040A1
SERIAL NO

15746397

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

In some aspects the present invention relates to engineered endothelial cells, such as E40RF1+ ETV2+ engineered endothelial cells. In other aspects the present invention relates to methods of making such engineered endothelial cells, and methods of using such engineered endothelial cells, for example in co-culture applications.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • Assignment data not available. Check PTO

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Davis, Claude Geoffrey Auburn, US 20 555
Finnegan, Paul William Del Mar, US 8 5
Ginsberg, Michael Daniel San Diego, US 10 7
Nolan, Daniel Joseph Hawthorne, US 10 12

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Sep 30, 2024
7.5 Year Payment $3600.00 $1800.00 $900.00 Sep 30, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 30, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00